The store will not work correctly when cookies are disabled.
US8575145, 106::US8575145, 66
ID: ALA3664634
PubChem CID: 67231289
Max Phase: Preclinical
Molecular Formula: C21H20FN5O
Molecular Weight: 377.42
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: FC1(COc2cccc3ccc(-c4nnc5ccccn45)nc23)CCNCC1
Standard InChI: InChI=1S/C21H20FN5O/c22-21(9-11-23-12-10-21)14-28-17-5-3-4-15-7-8-16(24-19(15)17)20-26-25-18-6-1-2-13-27(18)20/h1-8,13,23H,9-12,14H2
Standard InChI Key: XQTDEFZROIJVJH-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 32 0 0 0 0 0 0 0 0999 V2000
6.2385 -0.8914 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
5.2003 -1.4932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8990 -0.7455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6003 -1.4977 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5981 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5981 -3.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -3.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -3.0000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -5.2508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0843 -6.1089 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.5458 -7.5361 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.0450 -7.5380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0471 -8.6542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.5147 -8.3444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9803 -6.9185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9782 -5.8023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5105 -6.1121 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9026 -2.2040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9055 -3.7040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2059 -4.4515 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.5036 -3.6990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5007 -2.1990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 5 1 0
14 9 1 0
12 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 15 1 0
23 18 1 0
2 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
28 2 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 377.42 | Molecular Weight (Monoisotopic): 377.1652 | AlogP: 3.42 | #Rotatable Bonds: 4 |
Polar Surface Area: 64.34 | Molecular Species: BASE | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 9.82 | CX LogP: 1.98 | CX LogD: -0.38 |
Aromatic Rings: 4 | Heavy Atoms: 28 | QED Weighted: 0.59 | Np Likeness Score: -1.26 |
References
1. (2013) Triazolopyridine compounds as PIM kinase inhibitors, |